Literature DB >> 9793093

Anatomy-guided linear atrial lesions for radiofrequency catheter ablation of atrial fibrillation.

D Schwartzman1, K H Kuck.   

Abstract

The surgical atrial maze procedure has provided proof that atrial fibrillation can be cured by performing atrial incisions based on anatomical and electrophysiological principles. Preliminary reports of attempts at radiofrequency catheter ablation of atrial fibrillation utilizing an anatomy-based "linear incision" method have shown the feasibility of the method. However, postprocedural atrial fibrillation recurrence has been common and in addition new, uniform tachycardias have developed in some patients. Both of these outcomes may be in part due to incomplete or inconsistent lesion deployment. This article details the use of the CARTO system for deploying anatomy guided linear atrial lesions for the purpose of curing atrial fibrillation. The procedure is comprised of three phases, which are discussed in detail: (1) baseline map; (2) lesion deployment and; (3) lesion assessment. Using a single standard ablation electrode, lesions can be deployed safely, and complete lesions can be confirmed. Paradigms for right and left atrial incisions are proposed.

Entities:  

Mesh:

Year:  1998        PMID: 9793093     DOI: 10.1111/j.1540-8159.1998.tb00016.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  18 in total

1.  Linear ablation using an irrigated electrode electrophysiologic and histologic lesion evolution comparison with ablation utilizing a non-irrigated electrode.

Authors:  D Schwartzman; M Parizhskaya; W A Devine
Journal:  J Interv Card Electrophysiol       Date:  2001-03       Impact factor: 1.900

2.  Electrogram-guided radiofrequency catheter ablation of atrial tissue comparison with thermometry-guide ablation: comparison with thermometry-guide ablation.

Authors:  D Schwartzman; J J Michele; C T Trankiem; J F Ren
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

Review 3.  Recent advances in cardiac mapping techniques.

Authors:  C Schmitt; G Ndrepepa; I Deisenhofer; M Schneider
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

4.  Catheter ablation to suppress atrial fibrillation: evolution of technique at a single center.

Authors:  David Schwartzman; Raveen Bazaz; John Nosbisch
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

5.  Catheter ablation of persistent atrial fibrillation : Circumferential pulmonary vein ablation: beneficial effect of an additional linear lesion at the roof of the left atrium on the long-term outcome.

Authors:  Klaus Kettering; Dag-Hau Yim; Felix Gramley
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-07-10

6.  Catheter ablation of persistent atrial fibrillation : Long-term results of circumferential pulmonary vein ablation in combination with a linear lesion at the roof of the left atrium.

Authors:  Klaus Kettering; Dag-Hau Yim; Caroline Albert; Felix Gramley
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-04-24

7.  Catheter ablation of persistent atrial fibrillation : Beneficial effect of a short-term adjunctive amiodarone therapy on the long-term outcome.

Authors:  Klaus Kettering; Felix Gramley
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-04-26

8.  Catheter ablation of atrial fibrillation: Radiofrequency catheter ablation for redo procedures after cryoablation.

Authors:  Klaus Kettering; Felix Gramley
Journal:  World J Cardiol       Date:  2013-08-26

Review 9.  Ablation of atrial fibrillation.

Authors:  Eduardo B Saad; Nassir F Marrouche; Andrea Natale
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

10.  Catheter ablation of atrial fibrillation using the Navx-/Ensite-system and a CT-/MRI-guided approach.

Authors:  Klaus Kettering; Gerald F Greil; Michael Fenchel; Ulrich Kramer; Hans-Joerg Weig; Mathias Busch; Stephan Miller; Ludger Sieverding; Roman Laszlo; Juergen Schreieck
Journal:  Clin Res Cardiol       Date:  2009-03-13       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.